ALCZX
Price
$20.52
Change
-$0.30 (-1.44%)
Updated
Feb 21 closing price
Net Assets
151.78M
RERBX
Price
$54.18
Change
-$0.50 (-0.91%)
Updated
Feb 21 closing price
Net Assets
131.04B
Ad is loading...

ALCZX vs RERBX

Header iconALCZX vs RERBX Comparison
Open Charts ALCZX vs RERBXBanner chart's image
Alger International Opportunities Z
Price$20.52
Change-$0.30 (-1.44%)
VolumeN/A
Net Assets151.78M
American Funds Europacific Growth R2
Price$54.18
Change-$0.50 (-0.91%)
VolumeN/A
Net Assets131.04B
ALCZX vs RERBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ALCZX vs. RERBX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALCZX is a Buy and RERBX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RERBX has more cash in the bank: 131B vs. ALCZX (152M). RERBX pays higher dividends than ALCZX: RERBX (1.00) vs ALCZX (0.14). ALCZX was incepted earlier than RERBX: ALCZX (14 years) vs RERBX (23 years). ALCZX is a more actively managed with annual turnover of: 52.23 vs. RERBX (34.00). RERBX has a lower initial minimum investment than ALCZX: RERBX (250) vs ALCZX (500000). ALCZX annual gain was more profitable for investors over the last year : 5.45 vs. RERBX (0.62). ALCZX return over 5 years is better than : 27.09 vs. RERBX (4.32).
ALCZXRERBXALCZX / RERBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years23 years-
Gain YTD6.5976.549101%
Front LoadN/AN/A-
Min. Initial Investment500000250200,000%
Min. Initial Investment IRAN/AN/A-
Net Assets152M131B0%
Annual Yield % from dividends0.141.0014%
Returns for 1 year5.450.62881%
Returns for 3 years5.87-0.32-1,858%
Returns for 5 years27.094.32627%
Returns for 10 years49.5715.57318%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KFS7.66-0.01
-0.13%
Kingsway Financial Services
ENLV1.00-0.02
-1.81%
Enlivex Therapeutics Ltd
PGRE4.52-0.10
-2.16%
Paramount Group
PTC161.65-4.11
-2.48%
PTC
RNA31.12-1.41
-4.33%
Avidity Biosciences